Opportunities for health tech in 2021
Where we might see growth drive innovation in the healthcare industry amid COVID-19 and beyond
Read More
Search Results for: Alan Payne
Quotient Clinical takes private equity route
Quotient Clinical has joined other providers of outsourced development services, such as PPD, PRA International, ReSearch Pharmaceutical Services and Theorem Clinical Research, in staking its future on private-equity ownership.
Read More
A mark of success
The PharmaTimes Marketer of the Year, Communications Team of the Year, and Sales Awards 2018.
Read MoreNICE has good news for Astellas’ prostate cancer drug
The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending that people with hormone-relapsed prostate cancer that has spread to other parts of the body and have been treated with docetaxel should be given access to Astellas Pharma’s Xtandi (enzalutamide).
Read More- Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD
- Study reveals vitamin D-altered mouse gut bacteria provides better cancer immunity
- Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
- Study finds mechanical changes in tumour tissue offer new insights for cancer research
- Cambridge study finds AI more accurately assesses eye problems compared to doctors
